Tag Archives: azn

AstraZeneca Woos Shareholders With Promise Of Growth

British pharma giant AstraZeneca (AZN) announced a new drug approval Tuesday and rolled out a strategy to nearly double revenue over the next decade, furthering its quest to convince shareholders not to yield to Pfizer’s (PFE) takeover attempt. Shareholders did not seem excited, however, as AstraZeneca’s stock was down a fraction on the stock market today. Astra said that the FDA had approved Epanova, a treatment for severe hypertriglyceridaemia,

AstraZeneca Nixes New Bid As Pfizer Woos British PM

British big pharma AstraZeneca (AZN) turned down a second takeover bid from U.S. counterpart Pfizer (PFE) Friday, saying that the $106 billion offer was still too low. Pfizer’s stock dropped nearly 2%, while AstraZeneca’s held steady on the stock market today. As with Pfizer’s first bid, AstraZeneca’s board objected to the large proportion of stock in the $84.43-a-share offer. They also described Pfizer’s move as “tax-driven,” underscoring Wall

Pfizer Sweetens AstraZeneca Bid To $106.5 Billion

Pfizer (PFE) sweetened its bid for AstraZeneca (AZN) to about 63.1 billion pounds ($106.5 billion), aiming to bring the U.K.’s second-biggest drugmaker to the negotiating table. The offer values AstraZeneca at 50 pounds a share ($84.47) in cash and stock, New York-based Pfizer said in statement today. The London-based company rejected a proposal of 46.61 pounds a share, announced April 28. Pfizer is raising its bid after Chief